QED Pharmaceutical Implements CDISC Standards With SAS

QED Pharmaceutical Services has licensed SAS Clinical Data Integration to enable its drug development clients to more easily form partnerships with key biopharmaceutical companies.

“The availability of SAS Clinical Data Integration has made it possible for QED to efficiently implement complex data standards such as the CDISC standards,” said Dr. Ramana Kuchibhatla, Founder, QED. “This allows us to help our clients - predominantly small and sometimes virtual biopharmaceutical companies - achieve important milestones despite their size. Compliance with the latest CDISC standards makes growing drug developers like our clients very attractive partners to large pharma companies that are looking to in-license successful drug development programs. The overall value created by SAS Clinical Data Integration to both QED as a service company and our clients by making them attractive partners and ensuring regulatory compliance is tremendous.”

Sudipta K Sen, Regional Director South-East Asia, CEO & MD SAS India said, “We are happy to be associated with QED pharmaceutical. The new deployment strengthens our commitment as a partner to help organisations in taking accurate decisions and to create an impact on their business goals.”